Schindler (SCHP SW) – FY sales +25.2% at 11.106bn (vs cons 10.709bn) / EBIT 717m (vs cons 727m) / net profit 511m (vs cons 486m) / dividend CHF 1.30 (vs 0.90) / orders +24.1% Outlook: sees FY07 net of CHF 530m (ex 144m EUR cartel fine) (BB)

AdvancedDigitalBroadcast (ADBN SW) – FY sales 262.3m (vs cons 270.1) / gross p 84.4 (vs cons 86.9) / net loss -6.3m (vs cons -3.2m) Outlook: sees FY07 sales growth 22-27% (BB)

Oridion (ORIDN SW) – FY sales +23% at 34.64m / EBIT 3.82 (vs 1.91) / net cont. ops 3.7 (vs 1.75) Outlook: sees FY07 sales growth +5-7% - oper. margin 11-13% - problems at Physio-Control to hurt '07 revenue (BB)

Converium (CHRN SW) – SCOR offers CHF 21.11 (4CHF cash and 0.5 Scor-shares/per 1 Converium) (BB)

Holcim (HOLN VX) – offers CAD 36.50 for each St.Lawrence share (ST/A CN) – Holcim owns 79% of Total SLC voting rights – values min. stake CAD 571m (BB)

Novartis (NOVN VX) – gets approval letter for Galvus but FDA wants more data – new clinic trial needed – despite delay, Novartis sees FY07 goals unchanged (BB)

Roche (ROG VX) – suspends recruitment into phase II Cera study (non small lung cancer drug) because of imbalance in number of death – investigator says deaths unrelated to study – nevertheless Roche stops trial and will delay to seek approval until findings are out (BB)